ABCL - AbCellera Biologics to cut 10% of staff in business shakeup
2023-11-29 06:39:01 ET
More on AbCellera Biologics
- AbCellera Biologics Inc. (ABCL) Q3 2023 Earnings Call Transcript
- AbCellera's Clinical Carousel: High Risk, Higher Stakes
- AbCellera Biologics Q3 2023 Earnings Preview
- AbCellera expands its multi-target collaboration with Regeneron
- Seeking Alpha’s Quant Rating on AbCellera Biologics
For further details see:
AbCellera Biologics to cut 10% of staff in business shakeup